BI Asset Management Fondsmaeglerselskab’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,269
Closed -$50K 906
2025
Q1
$50K Buy
+6,269
New +$63.4K ﹤0.01% 797
2023
Q4
Sell
-51,199
Closed -$952K 783
2023
Q3
$952K Buy
+51,199
New +$1.2M 0.02% 383
2020
Q4
Sell
-11,215
Closed -$2.46M 476
2020
Q3
$2.46M Sell
11,215
-642
-5% -$136K 0.11% 160
2020
Q2
$2.26M Buy
+11,857
New +$2.08M 0.12% 165

Other funds holding TDOC

BI Asset Management Fondsmaeglerselskab's TDOC Position: Q2 2025 in Review

BI Asset Management Fondsmaeglerselskab sold out of Teladoc Health (TDOC) in Q2 2025, closing a stake of 6,269 shares — an estimated $50K sold.

BI Asset Management Fondsmaeglerselskab first reported a position in TDOC in Q2 2020 and held it in 4 quarters. The position peaked at $2.46M in Q3 2020. 359 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.

  • BI Asset Management Fondsmaeglerselskab reported no remaining Teladoc Health position as of Q2 2025 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 6,269 Teladoc Health shares in Q2 2025, an estimated $50K.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Teladoc Health in Q2 2020 and held it in 4 quarters.
  • BI Asset Management Fondsmaeglerselskab's Teladoc Health position peaked at $2.46M in Q3 2020.
  • 359 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2025, filed 14 Aug 2025.